Just a moment, the page is loading...

GSK-111442




Evaluation of effectiveness of GSK Biologicals’ pneumococcal conjugate vaccine 1024850A against invasive disease
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
111442
NCT00861380 2008-005149-48
Infections, Streptococcal
Phase 3
A nested study 112595 was conducted.
September 2015